NICOLE CUELLAR: Open Payments
NPI 1609389964 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 45 payments from 22 companies in 2025. Trend: 2023 $518 · 2024 $698 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 6 | $121 |
| Alpha Cognition USA, Inc. | 1 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Eisai Inc. | 2 | $60 |
| SHIELD THERAPEUTICS INC | 1 | $53 |
| ABBVIE INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: JARDIANCE, Zunveyl, REXULTI, Leqembi, The Cologuard Plus Collection Kit, ACCRUFER, AIRSUPRA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
